ArticleFrontiers in nuclear medicine2022

ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization.

Fabrizia Gelardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.